News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
110,176 Results
Type
Article (4997)
Company Profile (20)
Press Release (105156)
Section
Business (39918)
Career Advice (135)
Deals (6876)
Drug Delivery (6)
Drug Development (13992)
Employer Resources (11)
FDA (2498)
Job Trends (3110)
News (61740)
Policy (4342)
Tag
Academia (249)
Accelerated approval (6)
Adcomms (1)
Allergies (31)
Alliances (4736)
ALS (19)
Alzheimer's disease (266)
Antibody-drug conjugate (ADC) (62)
Approvals (2638)
Artificial intelligence (45)
Autoimmune disease (19)
Automation (3)
Bankruptcy (51)
Best Places to Work (2541)
Biosimilars (30)
Biotechnology (15)
Bladder cancer (47)
Brain cancer (7)
Breast cancer (147)
Cancer (979)
Cardiovascular disease (79)
Career advice (129)
Career pathing (4)
CAR-T (44)
CDC (2)
Cell therapy (124)
Cervical cancer (9)
Clinical research (13016)
Collaboration (181)
Compensation (151)
Complete response letters (3)
COVID-19 (351)
CRISPR (18)
C-suite (39)
Cystic fibrosis (21)
Data (1553)
Depression (17)
Diabetes (91)
Diagnostics (1140)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (27)
Drug pricing (13)
Drug shortages (3)
Duchenne muscular dystrophy (48)
Earnings (33118)
Editorial (3)
Employer branding (3)
Employer resources (9)
Events (18015)
Executive appointments (72)
FDA (3243)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (8)
Funding (126)
Gene editing (32)
Generative AI (4)
Gene therapy (92)
GLP-1 (156)
Government (715)
Grass and pollen (2)
Guidances (285)
Healthcare (3105)
HIV (10)
Huntington's disease (4)
IgA nephropathy (17)
Immunology and inflammation (49)
Immuno-oncology (5)
Indications (18)
Infectious disease (404)
Inflammatory bowel disease (39)
Influenza (25)
Intellectual property (21)
Interviews (21)
IPO (4476)
IRA (1)
Job creations (728)
Job search strategy (116)
Kidney cancer (7)
Labor market (15)
Layoffs (110)
Leadership (1)
Legal (718)
Liver cancer (11)
Longevity (1)
Lung cancer (130)
Lymphoma (127)
Machine learning (2)
Management (2)
Manufacturing (75)
MASH (47)
Medical device (2438)
Medtech (2444)
Mergers & acquisitions (2578)
Metabolic disorders (213)
Multiple sclerosis (35)
NASH (2)
Neurodegenerative disease (46)
Neuropsychiatric disorders (9)
Neuroscience (442)
NextGen: Class of 2025 (878)
Non-profit (502)
Now hiring (5)
Obesity (75)
Opinion (16)
Ovarian cancer (36)
Pain (31)
Pancreatic cancer (21)
Parkinson's disease (42)
Partnered (3)
Patents (34)
Patient recruitment (45)
Peanut (12)
People (3761)
Pharmaceutical (1)
Pharmacy benefit managers (5)
Phase I (3073)
Phase II (5342)
Phase III (5602)
Pipeline (1640)
Policy (13)
Postmarket research (508)
Preclinical (983)
Press Release (4)
Prostate cancer (50)
Psychedelics (1)
Radiopharmaceuticals (37)
Rare diseases (115)
Real estate (647)
Recruiting (4)
Regulatory (3600)
Reports (15)
Research institute (242)
Resumes & cover letters (7)
Rett syndrome (3)
RSV (15)
Schizophrenia (27)
Series A (19)
Series B (16)
Sickle cell disease (21)
Special edition (2)
Spinal muscular atrophy (18)
Sponsored (3)
Startups (363)
Stomach cancer (1)
Supply chain (12)
Tariffs (12)
The Weekly (3)
Vaccines (193)
Venture capital (10)
Weight loss (47)
Women's health (11)
Worklife (4)
Date
Today (15)
Last 7 days (83)
Last 30 days (430)
Last 365 days (7172)
2025 (7106)
2024 (7529)
2023 (8131)
2022 (9522)
2021 (9448)
2020 (8667)
2019 (7256)
2018 (5723)
2017 (6377)
2016 (4713)
2015 (5668)
2014 (3711)
2013 (2533)
2012 (2984)
2011 (3149)
2010 (2924)
Location
Africa (108)
Alabama (10)
Arizona (51)
Arkansas (2)
Asia (6801)
Australia (973)
California (2334)
Canada (625)
China (134)
Colorado (103)
Connecticut (79)
Delaware (103)
Europe (16367)
Florida (315)
Georgia (69)
Idaho (8)
Illinois (172)
India (9)
Indiana (123)
Japan (190)
Kansas (11)
Kentucky (7)
Louisiana (9)
Maine (19)
Maryland (334)
Massachusetts (1695)
Michigan (50)
Minnesota (96)
Mississippi (1)
Missouri (29)
Montana (3)
Nevada (23)
New Hampshire (8)
New Jersey (921)
New Mexico (3)
New York (625)
North Carolina (279)
Northern California (1191)
Ohio (66)
Oregon (1)
Pennsylvania (410)
Puerto Rico (1)
Rhode Island (2)
South America (164)
South Carolina (4)
Southern California (894)
Tennessee (25)
Texas (241)
United States (8316)
Utah (64)
Virginia (37)
Washington D.C. (6)
Washington State (174)
West Virginia (1)
Wisconsin (28)
110,176 Results for "45".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Jade Biosciences Announces $45 Million Private Placement
December 15, 2025
·
5 min read
Press Releases
Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “MIRACLE” Phase 3 AML Trial on Pace for Q1 2026
December 10, 2025
·
7 min read
Press Releases
Okami Medical Announces $45 Million Financing and New CEO Appointment to Drive Next Phase of Growth
November 20, 2025
·
3 min read
Press Releases
mRNA Therapeutics Market Size to Attain USD 45.04 Billion by 2034 | Vision Research Reports
November 13, 2025
·
1 min read
Press Releases
Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented
November 14, 2025
·
6 min read
Press Releases
Cell And Gene Therapy Clinical Trials Market Accelerates from USD 12.47 Billion in 2025 to USD 45.31 Billion by 2034
December 3, 2025
·
1 min read
Press Releases
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock
October 13, 2025
·
4 min read
Press Releases
Neuronoff Closes Oversubscribed $4.5M Round to Prepare Launch of Injectrode Platform for Chronic Pain
October 9, 2025
·
3 min read
Press Releases
Aethlon Medical Announces Pricing of $4.5 Million Public Offering
September 5, 2025
·
5 min read
Press Releases
YolTech Therapeutics Raises $45 Million in Series B Financing Led by AstraZeneca-CICC
September 12, 2025
·
1 min read
1 of 11,018
Next
